{
    "clinical_study": {
        "@rank": "161438", 
        "acronym": "LDK-SI", 
        "arm_group": [
            {
                "arm_group_label": "Ketamine", 
                "arm_group_type": "Experimental", 
                "description": "active arm"
            }, 
            {
                "arm_group_label": "Diphenhydramine", 
                "arm_group_type": "Sham Comparator", 
                "description": "sham arm"
            }, 
            {
                "arm_group_label": "Saline", 
                "arm_group_type": "Placebo Comparator", 
                "description": "placebo"
            }
        ], 
        "brief_summary": {
            "textblock": "This study will enroll patients presenting to the emergency department with acute suicidal\n      ideation meeting inclusion and exclusion criteria.  Patients will be randomized to one of\n      three arms: ketamine (intervention) or diphenhydramine (control) or placebo (control).\n      Serial measurements will be made in the ED and at follow-up intervals."
        }, 
        "brief_title": "Ketamine for Acute Suicidal Ideation in the Emergency Department: Randomized Controlled Trial", 
        "condition": "Suicide", 
        "condition_browse": {
            "mesh_term": [
                "Emergencies", 
                "Suicide", 
                "Suicidal Ideation"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Patients age 18 to less than 75 who present to the SAMMC ED with either overt or\n             incidental suicidal ideations with a SADPERSONS score 5 or greater that the treating\n             provider feels warrant formal evaluation.\n\n        Exclusion Criteria:\n\n          -  -Poor vital sign stability hypoxia: O2 < 95%, hypotension: SBP< 90 hypertension:\n             SBP>180 Heart rate: < 50 or >120 Respiratory Rate: <10 or >30\n\n          -  Altered mental status or intoxication\n\n          -  Patient is unwilling to participate or provide informed consent\n\n          -  Any allergy to ketamine or diphenhydramine\n\n          -  Patient is female of child-bearing age and unwilling to provide urine or blood for\n             HCG analysis\n\n          -  Pregnancy or breast feeding\n\n          -  Presence of chronic oxygen-dependent pulmonary disease, liver cirrhosis, or renal\n             disease requiring dialysis\n\n          -  Presence of ischemic heart disease, heart failure, or a history of unstable\n             dysrhythmias\n\n          -  Presence of intracranial mass or vascular lesion.\n\n          -  Presence of a history of psychosis or hallucinations (as assessed by electronic chart\n             review)\n\n          -  Weight greater than 115 kg or less than 45kg\n\n          -  History of increased  intracranial pressure/hypertensive hydrocephalus\n\n          -  Non-English speaking patients\n\n          -  Patient is acutely psychotic\n\n          -  Provider feels that patient currently or likely will require chemical and/or physical\n             restraints\n\n          -  History of prolonged QT-interval"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "75 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "53", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "July 2, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01892995", 
            "org_study_id": "BAMC-385833-1"
        }, 
        "intervention": {
            "arm_group_label": [
                "Ketamine", 
                "Diphenhydramine", 
                "Saline"
            ], 
            "intervention_name": "Ketamine", 
            "intervention_type": "Drug"
        }, 
        "intervention_browse": {
            "mesh_term": "Ketamine"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "suicide", 
            "ketamine", 
            "low-dose ketamine", 
            "suicidal ideations", 
            "emergency department"
        ], 
        "lastchanged_date": "July 2, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "Fort Sam Houston", 
                    "country": "United States", 
                    "state": "Texas", 
                    "zip": "78234"
                }, 
                "name": "Brooke Army Medical Center"
            }, 
            "status": "Not yet recruiting"
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "3", 
        "official_title": "Ketamine for Acute Suicidal Ideation in the Emergency Department: Randomized Controlled Trial", 
        "overall_contact": {
            "email": "sgschauer@gmail.com", 
            "last_name": "Steven G Schauer, DO", 
            "phone": "2109160808"
        }, 
        "overall_contact_backup": {
            "email": "shawn.m.varney.mil@mail.mil", 
            "last_name": "Shawn M Varney, DO", 
            "phone": "2109160808"
        }, 
        "overall_status": "Not yet recruiting", 
        "oversight_info": {
            "authority": "United States: Federal Government", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "December 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Change in Beck Scale for Suicidal Ideation", 
            "safety_issue": "No", 
            "time_frame": "2 hours"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01892995"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Brooke Army Medical Center", 
            "investigator_full_name": "Steven Schauer", 
            "investigator_title": "CPT", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "source": "Brooke Army Medical Center", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Brooke Army Medical Center", 
                "agency_class": "U.S. Fed"
            }
        }, 
        "start_date": "December 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "July 2013"
    }
}